233 related articles for article (PubMed ID: 12872083)
21. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
[TBL] [Abstract][Full Text] [Related]
23. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation.
Panjehpour M; Overholt BF; Haydek JM; Lee SG
Am J Gastroenterol; 2000 Sep; 95(9):2177-84. PubMed ID: 11007214
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy in Barrett's esophagus: results of treatment of 17 patients.
Weiss AA; Wiesinger HA; Owen D
Can J Gastroenterol; 2006 Apr; 20(4):261-4. PubMed ID: 16609754
[TBL] [Abstract][Full Text] [Related]
25. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
Weston AP; Sharma P
Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
[TBL] [Abstract][Full Text] [Related]
26. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
27. Molecular evaluation of ablative therapy of Barrett's oesophagus.
Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
[TBL] [Abstract][Full Text] [Related]
28. Esophageal squamous cell carcinoma arising after endoscopic ablation therapy of Barrett's esophagus with high-grade dysplasia. Report of a case.
Allende D; Dumot J; Yerian L
Dis Esophagus; 2013 Apr; 26(3):314-8. PubMed ID: 23009180
[TBL] [Abstract][Full Text] [Related]
29. Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett's associated neoplasia.
Kohoutova D; Haidry R; Banks M; Bown S; Sehgal V; Butt MA; Graham D; Thorpe S; Novelli M; Rodriguez-Justo M; Lovat L
Scand J Gastroenterol; 2015; 50(11):1315-21. PubMed ID: 25956748
[TBL] [Abstract][Full Text] [Related]
30. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Gossner L; May A; Sroka R; Ell C
Endoscopy; 1999 Jun; 31(5):370-6. PubMed ID: 10433046
[TBL] [Abstract][Full Text] [Related]
31. Present status of photodynamic therapy for high-grade dysplasia in Barrett's esophagus.
Wolfsen HC
J Clin Gastroenterol; 2005 Mar; 39(3):189-202. PubMed ID: 15718860
[TBL] [Abstract][Full Text] [Related]
32. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia.
Bronner MP; Overholt BF; Taylor SL; Haggitt RC; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Canto MI; Marcon N; Pedrosa M; Grace M; Depot M;
Gastroenterology; 2009 Jan; 136(1):56-64; quiz 351-2. PubMed ID: 18996379
[TBL] [Abstract][Full Text] [Related]
33. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
[TBL] [Abstract][Full Text] [Related]
34. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
35. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
Chatelain D; Fléjou JF
Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer.
Keeley SB; Pennathur A; Gooding W; Landreneau RJ; Christie NA; Luketich J
Ann Surg Oncol; 2007 Aug; 14(8):2406-10. PubMed ID: 17534685
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy in Barrett's esophagus.
Wang KK; Kim JY
Gastrointest Endosc Clin N Am; 2003 Jul; 13(3):483-9, vii. PubMed ID: 14629104
[TBL] [Abstract][Full Text] [Related]
38. Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up.
Sharma P; Jaffe PE; Bhattacharyya A; Sampliner RE
Gastrointest Endosc; 1999 Apr; 49(4 Pt 1):442-6. PubMed ID: 10202056
[TBL] [Abstract][Full Text] [Related]
39. The diagnosis and management of Barrett's esophagus.
DeMeester SR; DeMeester TR
Adv Surg; 1999; 33():29-68. PubMed ID: 10572561
[TBL] [Abstract][Full Text] [Related]
40. Treatment for Barrett's oesophagus.
Rees JR; Lao-Sirieix P; Wong A; Fitzgerald RC
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD004060. PubMed ID: 20091557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
